About Sanctus Global
Sanctus Global is a Healthcare company based in Chandigarh (India) founded in 2000. Various pharmaceutical products including tablets, capsules, and nutraceuticals are manufactured. Sanctus Global has raised $541.65 thousand across 2 funding rounds. The company has 108 employees. Sanctus Global was last valued at $1.15 million in February 2014. Its chief executive, as recorded, is Sahil Joshi. Its Indian entity Sanctus Global Formulations Limited reported revenue of ₹47.05 Cr. Sanctus Global offers products and services including Tablets, Capsules, Granules, and Contract Manufacturing. Its focus areas include Diversified Pharmaceuticals.
Company details
Sanctus Global was established in 2000 in Chandigarh, India, where pharmaceutical manufacturing operations are conducted. Tablets, capsules, DC granules, pellets, and nutraceuticals are produced as part of the core offerings. Additional healthcare products are also developed to support the sector. The focus remains on these production activities within the Indian pharmaceutical industry.
- Headquarters Chandigarh, India
- Employees 108
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sanctusglobal.com
- Social LinkedIn X Facebook Instagram
- Legal Name Sanctus Global Formulations Limited
- Date of Incorporation 21 Nov, 2000
- Jurisdiction Chandigarh, India
- Annual Revenue₹47.05 Cr
FY 2025 · +32% YoY
- Net Profit₹28.5 Lakh
FY 2025 · 1% margin
- EBITDA₹2.13 Cr
FY 2025 · 5% margin
- Total Equity Funding$541.65K (USD)
in 2 rounds
- Latest Funding Round$43.52K (USD), Angel Round
Feb 2014
- Employee Count108
Associated legal entities of Sanctus Global
Sanctus Global is associated with 2 registered companies on The Company Check; the primary company is Sanctus Global Formulations Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sanctus Global Formulations Limited CIN U29297CH2000PLC041530 | Active | 21 Nov 2000 | Chandigarh, Chandigarh | ₹47.0 Cr | 108 | 3 | View details |
| Sanctus Global Lifesciences Private Limited CIN U51909CH2017PTC041369 | Active | 06 Feb 2017 | Chandigarh, Chandigarh | ₹1.5 Cr | 2 | View details |
Products & Services of Sanctus Global
Sanctus Global offers a comprehensive portfolio of products and services, including Tablets, Capsules, Granules, and Contract Manufacturing.
Manufactures oral solid dosage forms for various health applications.
Produces encapsulated drugs for effective delivery and treatment.
Develops direct compression granules for pharmaceutical formulations.
Provides outsourced production of pharmaceutical products.
Funding Insights of Sanctus Global
Sanctus Global has successfully raised a total of $541.65K across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $43.52 thousand completed in February 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $541,649
- Total Rounds 2
- Last Round Angel Round — $43,518
- First Round $498,131
(Mar 2009)
All 2 funding rounds of Sanctus Global with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2014 | $43,518 | Angel Round | $1.15M | – | – |
| Mar 2009 | $498,131 | Angel Round | $1.35M | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Feb 2014 | $1.15M | •••••••• |
| Mar 2009 | $1.35M | •••••••• |
Last known valuation $1.15M (Feb 2014).
Board of directors of Sanctus Global Formulations Limited (Sanctus Global)
Sanctus Global Formulations Limited is the primary company behind Sanctus Global. The boards of the 2 registered companies of Sanctus Global currently have 3 directors; the longest-serving is Vijay Kumar Joshi, appointed in 2017. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vijay Kumar Joshi DIN 00525223 | Director | 06 Feb 2017 | 9 yrs 8 mo | Sanctus Global Lifesciences Private Limited, Sanctus Global Formulations Limited |
| Sahil Joshi DIN 07669407 | Director | 25 May 2022 | 4 yrs 5 mo | Sanctus Global Lifesciences Private Limited, Sanctus Global Formulations Limited |
| Sangeeta Joshi DIN 07802762 | Director | 06 Jan 2023 | 3 yrs 9 mo | Sanctus Global Formulations Limited |
People of Sanctus Global
1 people are tracked at Sanctus Global (1 in leadership); the tracked headcount is 108.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership |
Complete people profiles for Sanctus Global
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Sanctus Global
Figures of Sanctus Global Formulations Limited, the primary company behind Sanctus Global, for FY 2025. Revenue was ₹47.05 Cr (+32% year on year). Net profit was ₹28.5 Lakh (1% margin). EBITDA was ₹2.13 Cr (5% margin). Revenue has grown at a compounded annual rate of +7% over three years and +10% over five years.
- ₹47.05 CrRevenue · FY 2025 · +32% YoY
- ₹28.5 LakhNet profit · 1% margin
- ₹2.13 CrEBITDA · 5% margin
- ₹4.16 CrPaid-up capital
- 108Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sanctus Global Formulations Limited are on its company page.
Detailed financial statements for Sanctus Global
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Sanctus Global
4 dated milestones of Sanctus Global across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Sanctus Global is founded.
- Funding First funding round of $498K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round, of $44K.
Web traffic of Sanctus Global
The website of Sanctus Global (sanctusglobal.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 2% vs previous month
Websites whose visitors overlap most with Sanctus Global. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
sblifesciences.com | sblifesciences.com | 100% | – | ||
| zenactspharma.com | 98% | 1.4K | #10,654,073 | View details | |
metamorf.in | metamorf.in | 96% | #1,543,882 | – | |
| macrolabs.in | 94% | 4.4K | #4,690,758 | View details | |
nualterherbovet.in | nualterherbovet.in | 92% | #13,762,959 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Sanctus Global
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sanctus Global
Sanctus Global was founded in 2000 and raised its 1st funding round 9 years after it was founded.
Sanctus Global is headquartered in Chandigarh, India.
Sahil Joshi is the CEO of Sanctus Global, as recorded in our data.
Sanctus Global is a funded company, having raised a total of $541.65K across 2 funding rounds to date. The company's 1st funding round was a Angel Round of $498.13K, raised on Mar 2009.
Sanctus Global has 108 employees.
The primary company behind Sanctus Global, Sanctus Global Formulations Limited, reported revenue of ₹47.05 Cr for FY 2025, up 32% year on year.
Sanctus Global was established in 2000 in Chandigarh, India, where pharmaceutical manufacturing operations are conducted. Tablets, capsules, DC granules, pellets, and nutraceuticals are produced as part of the core offerings. Additional healthcare products are also developed to support the sector. The focus remains on these production activities within the Indian pharmaceutical industry.
Sanctus Global offers Tablets, Capsules, Granules, and Contract Manufacturing.
The valuation of Sanctus Global is $1.15M as of Feb 2014.
Sanctus Global is associated with 2 legal entities: Sanctus Global Formulations Limited, Sanctus Global Lifesciences Private Limited.
The legal entities of Sanctus Global currently have 3 directors, including Sahil Joshi, Vijay Kumar Joshi, Sangeeta Joshi.